Analystreport

Akari Therapeutics (AKTX) was downgraded by Maxim Group from "buy" to "hold".

Akari Therapeutics Plc - American Depositary Shares  (AKTX) 
US:NASDAQ Investor Relations: investor.akaritx.com/investor-relations